Impact of knowledge / innovation on merger and acquisition success in the pharmaceutical industry: The case of AstraZeneca/Ardea Biosciences and GlaxoSmithKline/Human Genome Sciences
Innovation is a key determinant of performance and competitive advantage. However, firms find it more and more difficult to remain innovating in an increasingly complex knowledge base economy. To counter this difficulty, this paper show that it is key for firms to be able to integrate external knowl...
| Main Author: | |
|---|---|
| Format: | Dissertation (University of Nottingham only) |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/45866/ |